Learn More
Antipsychotics currently available to treat schizophrenia suffer several limitations: (1) they are efficient against positive but not negative and cognitive symptoms of the disease; (2) they help(More)
Corrigendum to “In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2, 3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2one (D2AAK1) as a potential(More)
In this study, antidepressant-like effects of intra-cerebroventricularly administration of oxoisoaporphine derivatives in post stroke-depressive like behavior were examined through despair swimming(More)
  • 1